JP2024512069A5 - - Google Patents
Info
- Publication number
- JP2024512069A5 JP2024512069A5 JP2023558740A JP2023558740A JP2024512069A5 JP 2024512069 A5 JP2024512069 A5 JP 2024512069A5 JP 2023558740 A JP2023558740 A JP 2023558740A JP 2023558740 A JP2023558740 A JP 2023558740A JP 2024512069 A5 JP2024512069 A5 JP 2024512069A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- approximately
- composition according
- zolmitriptan
- release portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163165938P | 2021-03-25 | 2021-03-25 | |
| US63/165,938 | 2021-03-25 | ||
| US202263306377P | 2022-02-03 | 2022-02-03 | |
| US63/306,377 | 2022-02-03 | ||
| PCT/US2022/021738 WO2022204399A1 (en) | 2021-03-25 | 2022-03-24 | Pharmaceutical compositions comprising zolmitriptan |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512069A JP2024512069A (ja) | 2024-03-18 |
| JP2024512069A5 true JP2024512069A5 (enExample) | 2025-04-16 |
Family
ID=83397893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558740A Pending JP2024512069A (ja) | 2021-03-25 | 2022-03-24 | ゾルミトリプタンを含む医薬組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240189240A1 (enExample) |
| EP (1) | EP4313037A4 (enExample) |
| JP (1) | JP2024512069A (enExample) |
| KR (1) | KR20240004330A (enExample) |
| AU (1) | AU2022246101A1 (enExample) |
| BR (1) | BR112023019407A2 (enExample) |
| CA (1) | CA3213383A1 (enExample) |
| IL (1) | IL307194A (enExample) |
| MX (1) | MX2023011240A (enExample) |
| WO (1) | WO2022204399A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117017983B (zh) * | 2023-10-09 | 2023-12-22 | 中山大学 | 曲普坦类药物在制备抗感染药物中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20041689A1 (it) * | 2004-09-01 | 2004-12-02 | Bojidar Mihaylov Stankov | Nuove formulazioni di rilascio controllato contenenti 5-idrossitriptofano e triptofano |
| EP2240022B1 (en) * | 2008-01-09 | 2016-12-28 | Charleston Laboratories, Inc. | Bilayered tablets comprising oxycodone and promethazine |
| US20100179202A1 (en) * | 2009-01-14 | 2010-07-15 | Ajanta Pharma Limited. | Orally disintegrating composition of zolmitriptan |
| MY169068A (en) * | 2012-04-18 | 2019-02-12 | Contera Pharma Aps | Orally available pharmaceutical formulation suitable for improved management of movement disorders |
| MX2016010213A (es) * | 2014-02-07 | 2017-04-13 | Auspex Pharmaceuticals Inc | Formulaciones farmaceuticas novedosas. |
| DK3261640T3 (da) * | 2015-02-25 | 2022-07-11 | Univ California | 5ht-agonister til behandling af epilepsilidelser |
| JP2021529158A (ja) * | 2018-06-19 | 2021-10-28 | ナショナル ユニバーシティー オブ シンガポールＮａｔｉｏｎａｌ Ｕｎｉｖｅｒｓｉｔｙ ｏｆ Ｓｉｎｇａｐｏｒｅ | 様々な適応症についての生物学的利用能を向上させるための５−ヒドロキシトリプトファンの製剤 |
| CA3158781A1 (en) * | 2019-10-23 | 2021-04-29 | Michael Wood | Methods of treating the symptoms of autism spectrum disorder |
-
2022
- 2022-03-24 IL IL307194A patent/IL307194A/en unknown
- 2022-03-24 AU AU2022246101A patent/AU2022246101A1/en active Pending
- 2022-03-24 MX MX2023011240A patent/MX2023011240A/es unknown
- 2022-03-24 EP EP22776651.6A patent/EP4313037A4/en active Pending
- 2022-03-24 US US18/552,420 patent/US20240189240A1/en active Pending
- 2022-03-24 KR KR1020237036000A patent/KR20240004330A/ko active Pending
- 2022-03-24 WO PCT/US2022/021738 patent/WO2022204399A1/en not_active Ceased
- 2022-03-24 JP JP2023558740A patent/JP2024512069A/ja active Pending
- 2022-03-24 CA CA3213383A patent/CA3213383A1/en active Pending
- 2022-03-24 BR BR112023019407A patent/BR112023019407A2/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11207270B2 (en) | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | |
| EP1017370B1 (en) | MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs) | |
| JP5426018B2 (ja) | 易服用性固形製剤 | |
| CN102869351B (zh) | 用于吸附剂在肠内的经口递送的制剂 | |
| JP4216912B2 (ja) | 結腸送逹のための多層腸溶性ポリマーコーティングを有するビサコジル投与形態 | |
| JP5976657B2 (ja) | 易服用性固形製剤 | |
| EP2424365A1 (en) | Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics | |
| JP2013512250A5 (enExample) | ||
| JP2008503475A5 (enExample) | ||
| WO2009047801A1 (en) | Therapeutic combinations and compositions for the treatment of gastrointestinal disorders | |
| CN101534792A (zh) | 包含氧可酮的粒剂和口腔崩解片剂 | |
| AU2017252410A1 (en) | Oral pharmaceutical compositions of mesalazine | |
| CA2906378C (en) | Controlled release pharmaceutical dosage forms | |
| JP6294400B2 (ja) | 易服用性固形製剤 | |
| WO2009027786A2 (en) | Matrix dosage forms of varenicline | |
| CN1832736A (zh) | 加巴喷丁的稳定缓释口服剂型 | |
| JP2001511450A5 (enExample) | ||
| JP6688819B2 (ja) | 易服用性固形製剤 | |
| WO2024165966A1 (en) | Gastroretentive extended release compositions of riociguat | |
| EP3727365A2 (en) | Modified release formulations of flurbiprofen | |
| EP3796908A1 (en) | Controlled release propiverine formulations | |
| JP2026503785A (ja) | 免疫疾患もしくは障害の予防または治療方法に使用するためのマクロライド | |
| HK40113418A (en) | Compositions comprising ciprofloxacin and celecoxib | |
| HK40092747A (en) | Gastro retentive dosage forms comprising deutetrabenazine | |
| CN101784264A (zh) | 用于延长释放的药物制剂 |